HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cellular localization of pituitary adenylate cyclase-activating peptide (PACAP) following traumatic brain injury in humans.

Abstract
The pituitary adenylate cyclase-activating peptide (PACAP) is involved in many processes of the developing and mature central nervous system, such as proliferation, differentiation, apoptosis, neurotransmission, inflammation and neuroprotection. Alternative posttranslational processing of PACAP results in two biologically active, amidated 27- and 38-amino acid peptides termed PACAP27 and PACAP38. In the present study, we examined whether traumatic brain injury (TBI) affects cellular immunopositivity for PACAP27 and PACAP38. Patients (n = 55) were classified into three groups dependent on their survival time (under 24 h, between 24 h and 7 days and between 7 days and 99 days postinjury). PACAP27 and PACAP38 were expressed by neurons and glial cells in normal human neocortex (n = 10). Following TBI, the total number of PACAP27- and PACAP38-positive cells was significantly decreased for a prolonged survival period within the traumatized neocortex. In the pericontusional cortex, the number of cells expressing PACAP27 and PACAP38 was significantly increased at all survival times examined. Triple immunofluorescence examinations revealed a significant increase in the absolute numbers of GFAP-positive reactive astrocytes as well as a decrease in the CNP-positive oligodendrocytes, each coexpressing PACAP27 or PACAP38 in the contusional and pericontusional cortex. We hypothesize that the increase of glial PACAP immunoreactivity may be interpreted as part of a complex endogenous neuroprotective response in the pericontusional regions, but the precise role of PACAP following TBI is yet to be determined.
AuthorsFrank K H van Landeghem, Thorsten Weiss, Manfred Oehmichen, Andreas von Deimling
JournalActa neuropathologica (Acta Neuropathol) Vol. 113 Issue 6 Pg. 683-93 (Jun 2007) ISSN: 0001-6322 [Print] Germany
PMID17431645 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glial Fibrillary Acidic Protein
  • Pituitary Adenylate Cyclase-Activating Polypeptide
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Injuries (metabolism, pathology)
  • Cell Count
  • Cerebral Cortex (metabolism, pathology)
  • Female
  • Fluorescent Antibody Technique
  • Glial Fibrillary Acidic Protein (metabolism)
  • Humans
  • Immunohistochemistry
  • Infant
  • Male
  • Middle Aged
  • Neurons (metabolism, pathology)
  • Oligodendroglia (metabolism, pathology)
  • Pituitary Adenylate Cyclase-Activating Polypeptide (metabolism)
  • Survival
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: